264 related articles for article (PubMed ID: 27834631)
1. FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model.
Kam TI; Park H; Gwon Y; Song S; Kim SH; Moon SW; Jo DG; Jung YK
Elife; 2016 Nov; 5():. PubMed ID: 27834631
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of amyloid β-FcγRIIb neurotoxicity and tau pathologies by targeting LYN.
Gwon Y; Kim SH; Kim HT; Kam TI; Park J; Lim B; Cha H; Chang HJ; Hong YR; Jung YK
FASEB J; 2019 Mar; 33(3):4300-4313. PubMed ID: 30540497
[TBL] [Abstract][Full Text] [Related]
3. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
[TBL] [Abstract][Full Text] [Related]
4. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
5. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
7. Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease.
Lim JW; Kim SK; Choi SY; Kim DH; Gadhe CG; Lee HN; Kim HJ; Kim J; Cho SJ; Hwang H; Seong J; Jeong KS; Lee JY; Lim SM; Lee JW; Pae AN
Eur J Med Chem; 2018 Sep; 157():405-422. PubMed ID: 30103190
[TBL] [Abstract][Full Text] [Related]
8. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
9. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
10. FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.
Kam TI; Song S; Gwon Y; Park H; Yan JJ; Im I; Choi JW; Choi TY; Kim J; Song DK; Takai T; Kim YC; Kim KS; Choi SY; Choi S; Klein WL; Yuan J; Jung YK
J Clin Invest; 2013 Jul; 123(7):2791-802. PubMed ID: 23921129
[TBL] [Abstract][Full Text] [Related]
11. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
Zhang ZX; Zhao RP; Wang DS; Li YB
Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
[TBL] [Abstract][Full Text] [Related]
12. Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.
Ando K; Küçükali F; Doeraene E; Nagaraj S; Antonelli EM; Thazin Htut M; Yilmaz Z; Kosa AC; Lopez-Guitierrez L; Quintanilla-Sánchez C; Aydin E; Ramos AR; Mansour S; Turbant S; Schurmans S; Sleegers K; Erneux C; Brion JP; Leroy K;
Acta Neuropathol; 2024 Jun; 147(1):94. PubMed ID: 38833073
[TBL] [Abstract][Full Text] [Related]
13. Aβ modulates actin cytoskeleton via SHIP2-mediated phosphoinositide metabolism.
Lee HN; Sim KM; Kim H; Ju J; Pae AN; Park JB; Ryu H; Seong J
Sci Rep; 2019 Oct; 9(1):15557. PubMed ID: 31664099
[TBL] [Abstract][Full Text] [Related]
14. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
[TBL] [Abstract][Full Text] [Related]
15. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
[TBL] [Abstract][Full Text] [Related]
18. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
[TBL] [Abstract][Full Text] [Related]
19. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
20. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]